[1] 孙倩莱, 高立冬, 胡世雄, 等. 2009-2015年湖南省手足口病死亡病例临床与流行病学特征分析[J]. 实用预防医学, 2017, 24(2):148-151. [2] 赵善露,罗垲炜,胡世雄,等. 湖南省2008-2015年手足口病暴发疫情流行特征分析[J].中国热带医学,2016, 16 (9):890-893. [3] 中国疾病预防控制中心. 肠道病毒EV71型灭活疫苗使用技术指南[EB/OL].(2016- 06-08)[2016-08-10]. http://www.gmw.chinacdc.cn/zxdt/201606/t20160608-131032.htm. [4] Dafang Z, Wensheng H, Hongyan R, et al. The influences of temperature on spatiotemporal trends of hand-foot-and-mouth disease in mainland China[J]. Int J Environ Health Res, 2014, 24(1):1-10. [5] 曾舸,罗垲炜,胡世雄,等. 湖南省2009-2015年手足口病重症病例流行病学分析[J].中国热带医学,2017,17 (2):143-146. [6] Ben CE, Wiener WY, Shulman LM, et al. Coxsackievirus A6-related hand, foot and mouth disease: skin manifestations in a cluster of adult patients[J]. J Clin Virol, 2014, 59(3):201-203. [7] Gong MQ, Zhu HT, Zhou J, et al. Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus A16 virus-like particles provides a structural basis for vaccine development[J]. J Virol, 2014, 88(11):6444-6452. [8] 梁静, 林志萍, 肖丽. 深圳市福田区2011-2015年手足口病的流行特征分析[J].中国热带医学,2016 ,16 (10):1017-1020. [9] 梅茂冬. 江苏省滨海县幼儿家长对手足口病疫苗的可接受性及其影响因素分析[J]. 现代医学, 2016, 44(1):47-51. [10] 叶新, 何剑锋, 孙立梅, 等. 广州市3岁及以下儿童监护人肠道病毒71型认知及其灭活疫苗自费接种意愿调查[J]. 疾病监测, 2017, 32(3):252-257. [11] Li YP, Liang ZL, Xia JL, et al. Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase ii, randomized, double-blind, placebo -controlled trial[J]. J Infect Dis, 2014, 209(1):46-55. [12] Liang Y, Zhou X, Yang E, et al. Analysis of the Th1/Th2 reaction in the immune response induced by EV71 inactivated vaccine in neonatal rhesus monkeys[J]. J Clin Immunol, 2012, 32(5):1048-1058. [13] Wang SM, Liu CC. Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine[J]. Expert Rev Anti Infect Ther, 2014, 12(4):447-456. [14] Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China[J]. N Engl J Med, 2014, 370(9):818-828.
2018, Vol. 25 
